(19)
(11) EP 4 680 627 A1

(12)

(43) Date of publication:
21.01.2026 Bulletin 2026/04

(21) Application number: 24769609.9

(22) Date of filing: 12.03.2024
(51) International Patent Classification (IPC): 
C07K 14/47(2006.01)
A61K 39/395(2006.01)
C07K 7/06(2006.01)
C07K 16/18(2006.01)
C07K 19/00(2006.01)
C12N 15/12(2006.01)
C12N 15/87(2006.01)
A61K 39/00(2006.01)
A61P 35/00(2006.01)
C07K 14/725(2006.01)
C07K 16/30(2006.01)
C12N 5/10(2006.01)
C12N 15/86(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; C12N 15/85; C12N 5/0693; C07K 14/4748; A61K 39/0011; C07K 7/06
(86) International application number:
PCT/CA2024/050300
(87) International publication number:
WO 2024/187278 (19.09.2024 Gazette 2024/38)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 13.03.2023 US 202363489855 P
24.07.2023 US 202363515149 P

(71) Applicant: Université de Montréal
Montréal, Québec H3T 1J4 (CA)

(72) Inventors:
  • PERREAULT, Claude
    Montréal, Québec H2V 2X1 (CA)
  • THIBAULT, Pierre
    Montreal, Québec H2M 2M8 (CA)
  • HARDY, Marie-Pierre
    Terrebonne, Québec J6Y 0A5 (CA)
  • VINCENT, Krystel
    Terrebonne, Québec J6W 0B4 (CA)
  • APAVALOAEI, Anca
    New York, New York 10044 (US)

(74) Representative: Mathys & Squire 
The Shard 32 London Bridge Street
London SE1 9SG
London SE1 9SG (GB)

   


(54) NOVEL TUMOR ANTIGENS FOR LUNG CANCER AND USES THEREOF